Reduced risk of post ERCP pancreatitis in statin users

BACKGROUND: One of the most feared complications of endoscopic retrograde cholangiopancreatography (ERCP), with an incidence of 3.5 to 15%, is post ERCP pancreatitis (PEP). Given the role of statins in the reduction of systemic and pancreatic intraluminal inflammation, we hypothesized that the use o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadi, Yousaf Bashir, Naqvi, Syeda Fatima, Abdelqader, Abdelhai, Kupec, Justin, Nasr, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181588/
https://www.ncbi.nlm.nih.gov/pubmed/32326889
http://dx.doi.org/10.1186/s12876-020-01264-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181588/
https://www.ncbi.nlm.nih.gov/pubmed/32326889
http://dx.doi.org/10.1186/s12876-020-01264-5

Ejemplares similares